RxDoctor Payments Data

Stephanie Morris, NP

Family · Lawton, OKNPI 1245744986

Payments from drug & device makers

$1,262in general payments, 2019–2025

Across 51 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$167
  • Edwards Lifesciences$148
  • Boston Scientific$121
  • AbbVie$120
  • Sumitomo Pharma America, Inc.$93
  • Ferring Pharmaceuticals Inc.$73
  • plus $541 from 15 others

What the payments were for

  • Food & beverage$1,262100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,262 in reported general payments places this provider in the 70th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$78,037
Medicare patients
468
Services billed
17,898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron111$96,611
GemtesaVibegron45$27,676
Tamsulosin Hcl416$6,239
Methenamine Hippurate69$5,061
Trimethoprim48$5,044
NitrofurantoinNitrofurantoin Macrocrystal115$4,926
Tolterodine Tartrate ErTolterodine Tartrate80$4,595
Finasteride199$3,254
Oxybutynin Chloride ErOxybutynin Chloride95$2,506
Alfuzosin Hcl ErAlfuzosin Hcl46$1,099
Solifenacin Succinate55$1,056
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst50$659
Dutasteride12$376
Ciprofloxacin Hcl59$365
Cephalexin36$359

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$46$96,611111 claims
Sumitomo Pharma America, Inc.Gemtesa$93$27,67645 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,026 family providers in Oklahoma.

Other family in Lawton

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →